ZUBIQO.
AI & MLCryptoFinanceBig TechAI Models
CybersecurityGamingEVs & Clean EnergyRoboticsAerospaceBiotech & Health
Enterprise
ZUBIQO.

High-magnitude intelligence briefs for the tech and finance sectors. Zero fluff. Maximum signal.

[email protected]
X (Twitter)ThreadsTelegramBlueskyMastodon

Sections

  • AI & ML
  • Crypto
  • Finance
  • Big Tech
  • Cybersecurity
  • Gaming
  • EVs & Clean Energy
  • Robotics
  • Aerospace
  • Biotech & Health

Publication

  • About Us
  • Editorial Ethics
  • Partner With Us
  • Contact Us

Tools

  • AI Models Pricing

Legal

  • Privacy Policy
  • Terms of Service
  • Fair Use & DMCA

Disclaimer:Zubiqo Intelligence operates as a technology-enabled news and research publication under human editorial oversight. The news briefs, market analysis, "Magnitude Scores", and "Community Sentiment" metrics provided on this platform are strictly for informational and educational purposes only. They do not constitute financial, legal, investment, or trading advice. Cryptocurrencies and financial markets are highly volatile; always conduct your own research and consult with a licensed professional before making any investment decisions. By using this site, you agree to our Terms of Service.

© 2026 Zubiqo Intelligence. All rights reserved.

Search Intelligence

Results for: "drug discovery"

Basecamp Research Raises $140M for 28B Parameter Cell Therapy AI
Biotech/Health
39 minutes ago•1 min read

Basecamp Research Raises $140M for 28B Parameter Cell Therapy AI

Zubiqo Take

"Generating novel DNA sequences is the easy part of computational biology; Basecamp's actual moat is using AI to solve the physical delivery problem via engineered bacteriophages."

BullishMag 7
SiliconANGLE
Novo Inks Deal With Anthropic to Deploy Claude AI for Drug Discovery
AI
7 days ago•1 min read

Novo Inks Deal With Anthropic to Deploy Claude AI for Drug Discovery

Zubiqo Take

"Rebranding and buying up API access to every major frontier lab is the standard corporate playbook when your core obesity market share starts slipping."

Mag 6
pharmaphorum
Bill Gates and Jeff Bezos Resurrect LifeMine's Drug Discovery Platform With $188M Series E
Startup
about 2 months ago•1 min read

Bill Gates and Jeff Bezos Resurrect LifeMine's Drug Discovery Platform With $188M Series E

Zubiqo Take

"Tech billionaires are stepping in to bankroll the capital-intensive scientific platforms that traditional pharma is currently too risk-averse to fund."

BullishMag 8
Fierce Biotech
Enveda Secures $311M Series E to Push AI-Discovered, Nature-Derived Drugs into Human Trials
Biotech/Health
about 2 hours ago•1 min read

Enveda Secures $311M Series E to Push AI-Discovered, Nature-Derived Drugs into Human Trials

Zubiqo Take

"AI platforms mapping evolutionary biology make for excellent pitch decks, but an $845M capital stack means these specific Phase 2 clinical trials have absolutely zero margin for error."

BullishMag 7
CryptoBriefing
Anthropic Proves Claude Can Design Novel Protein Binders In Major Biotech Push
AI
about 1 month ago•1 min read

Anthropic Proves Claude Can Design Novel Protein Binders In Major Biotech Push

Zubiqo Take

"Selling API credits to software devs is cute, but autonomous drug discovery is the real endgame for AI valuations."

BullishMag 8
Anthropic
Former OpenAI CPO Kevin Weil Seeks $150M For New Science AI Startup
Startup
about 1 month ago•1 min read

Former OpenAI CPO Kevin Weil Seeks $150M For New Science AI Startup

Zubiqo Take

"The frontier lab diaspora is realizing it's far more lucrative to build proprietary data pipelines for drug discovery than to fight over consumer chatbot subscriptions."

Mag 7
Business Insider